Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02040337 · ClinicalTrials.gov registry record

Sequencing T-cells in Type I Diabetes Mellitus

A clinical trial, sponsored by Seton Healthcare Family.

Completed
Registry status
40
Enrollment target

NCT02040337: Completed study, sponsored by Seton Healthcare Family.

NCT02040337 is a clinical trial that has completed, run by Seton Healthcare Family. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02040337 has completed, sponsored by Seton Healthcare Family.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

The purpose of this study is to investigate CD8 + T-cell receptor (TCR) repertoire differences between patients with type 1 diabetes mellitus and type 2 diabetes or healthy controls.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-04
Est. Completion 2017-12-13
Seton Healthcare Family

15 total trials

What the finished NCT02040337 record still lists

NCT02040337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02040337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02040337 about?

NCT02040337 is a clinical study titled "Sequencing T-cells in Type I Diabetes Mellitus". The purpose of this study is to investigate CD8 + T-cell receptor (TCR) repertoire differences between patients with type 1 diabetes mellitus and type 2 diabetes or healthy controls.

What is the current status of trial NCT02040337?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-04. Estimated completion is 2017-12-13.

Who is sponsoring clinical trial NCT02040337?

This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02040337, the US trial registry maintained by the National Library of Medicine. NCT02040337 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.